Abstract
Short interfering RNA (siRNA) is widely used for studying gene function and holds great promise as a tool for validating drug targets and treating disease. A critical assumption in these applications is that the effect of siRNA on cells is specific, i.e., limited to the specific knockdown of the target gene. In this article, we characterize the specificity of siRNA by applying gene expression profiling. Several siRNAs were designed against different regions of the same target gene for three different targets. Their effects on cells were compared by using DNA microarrays to generate gene expression signatures. When the siRNA design and transfection conditions were optimized, the signatures for different siRNAs against the same target were shown to correlate very closely, whereas the signatures for different genes revealed no correlation. These results indicate that siRNA is a highly specific tool for targeted gene knockdown, establishing siRNA-mediated gene silencing as a reliable approach for large-scale screening of gene function and drug target validation.
References
35
Referenced
381
- McManus, M. T. & Sharp, P. A. (2002) Nat. Rev. Genet. 10, 737–747. / Nat. Rev. Genet. (2002)
10.1073/pnas.171251798
10.4049/jimmunol.169.10.5754
10.1126/science.1072802
10.1038/ncb892
10.1038/35078107
- Zou, X., Ray, D., Aziyu, A., Christov, K., Boiko, A. D., Gudkov, A. V. & Kiyokawa, H. (2002) Genes Dev. 15, 2923–2934. / Genes Dev. (2002)
10.1038/nm0702-659
10.1038/nm828
10.1101/gad.862301
10.1101/gad.880001
10.1038/nsb0901-746
- Bernstein, E., Denli, A. M. & Hannon, G. J. (2001) RNA 7, 1509–1521.11720281 / RNA (2001)
10.1093/emboj/20.23.6877
10.1021/bi000558j
10.1016/S0968-0004(97)01155-9
10.1146/annurev.pharmtox.41.1.403
10.1038/nm1195-1119
10.1074/jbc.M203347200
10.1073/pnas.171314398
10.1073/pnas.96.18.10033
10.1073/pnas.211566398
10.1038/415530a
10.1038/35020115
- Pruitt, K. & Maglott, D. R. (2001) Nucleic Acids Res. 21, 137–140. / Nucleic Acids Res. (2001)
10.1021/bi9809425
10.1101/gad.1064703
10.1242/jcs.114.24.4557
10.1038/sj.onc.1205102
10.1038/sj.onc.1204230
10.1073/pnas.052010099
10.1038/35008695
- Sellers, W. R. & Kaelin, W. G., Jr. (1997) J. Clin. Oncol. 3, 1145–1149. / J. Clin. Oncol. (1997)
10.1016/S0167-4781(99)00148-7
10.1016/S1097-2765(02)00651-2
Dates
Type | When |
---|---|
Created | 22 years, 3 months ago (May 27, 2003, 1:10 p.m.) |
Deposited | 3 years, 4 months ago (April 25, 2022, 9:24 p.m.) |
Indexed | 2 days, 15 hours ago (Sept. 3, 2025, 6:23 a.m.) |
Issued | 22 years, 3 months ago (May 13, 2003) |
Published | 22 years, 3 months ago (May 13, 2003) |
Published Online | 22 years, 3 months ago (May 13, 2003) |
Published Print | 22 years, 3 months ago (May 27, 2003) |
@article{Semizarov_2003, title={Specificity of short interfering RNA determined through gene expression signatures}, volume={100}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.1131959100}, DOI={10.1073/pnas.1131959100}, number={11}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Semizarov, Dimitri and Frost, Leigh and Sarthy, Aparna and Kroeger, Paul and Halbert, Donald N. and Fesik, Stephen W.}, year={2003}, month=may, pages={6347–6352} }